Amylin wins TRO against longtime partner Lilly; Neurosearch, 4SC scout for partners; Your brain on video games;

@FierceBiotech: Pfizer investigator questions cause of deaths in tofacitinib trial. News | Follow @FierceBiotech

@JohnCFierce: The $1B federal Therapeutic Discovery Program was a big hit with thousands of biotechs--now there's a new bill to add $7B more through 2017. | Follow @JohnCFierce

> Amylin has won the first round in its explosive case against Eli Lilly--a longtime development partner--as a U.S. District Judge issues a temporary restraining order against Lilly's co-marketing deal with rival Boehringer Ingelheim. Story

> Now that it's received U.S. and European regulatory feedback from Neurosearch for its obesity drug candidate, the Danish company says it is looking for a partner to take it forward. The feedback has given the biotech some key insights into the design of its clinical program for the drug. Article

> Bloomberg reports that 4SC is hoping that upcoming mid-stage data will set the stage for a partnership deal for its rheumatoid arthritis program. Item

> BioCis Pharma Oy and Oy Lx Therapies have combined to create Laurantis Pharma, a clinical-stage specialty pharmaceutical development company. The company's lead products target the treatment of a variety of inflammatory diseases and conditions including atopic dermatitis, dry eye syndrome, interstitial cystitis, and lymphatic disorders, as well as the treatment of bladder cancer. Release

> Arena Pharmaceuticals presented meta-analyses of the three trials in the lorcaserin Phase III clinical trial program at ECO 2011, the 18th European Congress on Obesity. Arena release

Pharma News

@FiercePharma: Vertex to field small, specialized sales force on Incivek. Item | Follow @FiercePharma

> Novartis aims for gout indication for Ilaris. Article

> NICE hurries to assess new hepatitis C drugs. Item

> Watson expands in Europe with $562M Specifar buy. News

> Nuedexta next in line for congressional questions. Story

> Bayer bias suit grows with new plaintiffs. Report

Vaccines News

> A look at HIV/AIDS vaccines in development. Story

> Prima BioMed to raise cash for ovarian cancer vaccine trial. News

> Systems biology key to vaccine breakthroughs? Report

> WHO: Smallpox vials around until at least 2014. Article

> Profectus immunizes first patient in Ph1 HIV vax trial. Item

Manufacturing News

> Cargo theft report puts pharma in 10th place. Story

> Pharma among NJ networks to seek info on employer skill needs. Item

> More wastewater treatment to keep drugs out of food. Report

> CMO Gallus taps Xcellerex for single-use capacity. Article

> Skills upgrade pulls manufacturing westward. Story

> CMOs boost R&D companies to top of efficiency ratings. News

And Finally... A new University of Missouri study suggests that the brains of violent video game players become less responsive to violence, and this diminished brain response predicts an increase in aggression. Release